Nicox completed the Denali Phase 3 trial for NCX 470, targeting open-angle glaucoma and ocular hypertension. NCX 470 combines ...

Patients with a common eye condition risk losing their sight permanently due to delays in care, experts have warned. The ...

3.2 Eligible study characterization As clearly implied in Table 1, this study included 19 RCTs conducted in rats, rabbits, and mice mainly. Six studies were conducted based on a glaucoma animal model ...

A deep learning model is capable of using optic disc photos to predict changes to their RNFL, a risk factor for glaucoma.

AIM The effect of breathing 100% oxygen on retinal and optic nerve head capillary blood flow in smokers and non-smokers was investigated using scanning laser Doppler flowmetry (SLDF) as a new ...

NAION risk is most significant within the first 12 months of beginning semaglutide, and is highest in patients with additional risk factors.